Simultaneous Treatment of Moderate-to-Severe Horizontal Frontalis Lines, Glabellar Lines, and Lateral Canthal Lines wtih OnabotulinumtoxinA from the Subject’s Perspective: Patient-Reported Satisfaction and Impact Outcomes from a Phase 3 Double-Blind Study. (2017). SKIN The Journal of Cutaneous Medicine, 1(3.1), s88. https://doi.org/10.25251/skin.1.supp.87